47 Although these studies present compelling findings regarding the economic impact of epilepsy, material limitations associated with common retrospective health economics research and real-world ...

(RTTNews) - NeuroOne Medical Technologies Corporation (NMTC), on Tuesday that CEO Dave Rosa was featured on Today's Marketplace or TMP, discussing the latest advancements in epilepsy treatment ...

“The addition of these five esteemed scientists to our SAB reflects our deepening clinical focus on epilepsy ... These factors include the company’s financial position and operational runway ...

Argent BioPharma, a clinical-stage pharmaceutical company that specialises in central nervous system and immune-related diseases, has entered the Australian Stock Exchange.

Bright Minds Biosciences (DRUG) announced the expansion of its Scientific Advisory Board to include five distinguished experts in epilepsy ...

He leads a large translational research team undertaking both basic studies and clinical studies focused on developing improved treatments for people with epilepsy and related brain diseases ...

Detailed price information for Bright Minds Biosciences Inc (DRUG-Q) from The Globe and Mail including charting and trades.